PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

PharmCyte already has ODD from FDA for Pancreatic Cancer. Evidently, we are on track for FDA approval.

The study to which was referred "analyzed the outcomes of 59 phase III clinical trials of cancer drugs going back 10 years, stratified by the market value of the companies four months prior to trial results being announced."

Cell in a Box(R) is not a cancer drug. It is a delivery device that utilizes an already FDA approved cancer drug. Therefore, the approval for PMCB will be for the treatment combo of ifosfomide (FDA approved) using CIAB (a delivery device). No cancer drug will be seeking approval.

Hopefully, others can follow this logic...